Literature DB >> 3080297

Stimulation of duodenal bicarbonate secretion by misoprostol.

B Smedfors, C Johansson.   

Abstract

Graded doses of topical misoprostol were examined for effects on duodenal bicarbonate output in fasted conscious rats and compared with perfusions of the H2-receptor blocker cimetidine. Chronic loops (2 cm) of the proximal duodenum were prepared in male Sprague-Dawley rats weighing 250 g. A thin perfusion tube was placed in the duodenal bulb, and a permanent cannula drained the distal end to the exterior. The stomach and remaining duodenum with biliary and pancreatic ducts were then reanastomosed. During tests, the loops were perfused with isotonic saline at 0.5 ml/min and samples of 15-min effluents analyzed for HCO3- using a modified back-titration method. Drugs and stimulants were added to the perfusion fluid. Misoprostol at 10(-10) M significantly (P less than 0.02) elevated the duodenal HCO3- from basal value (N = 10), and concentrations of 10(-10) to 4 X 10(-4) M produced dose-dependent increases of bicarbonate secretion, with a peak output of 49 +/- 7 mumol/cm/hr. A peak response of the same magnitude, 42 +/- 4 mumol/cm/hr, is observed after 5-min exposure of the loops to 150 mm HCl. The response to a single dose of 10(-4) M misoprostol was sustained, similar to the prolonged stimulatory effects of 5-min acid exposure. Perfusions of the loop with graded natural PGE2 result in similar increases of duodenal HCO3-, but the peak may be lower and the response to a single dose is less sustained. The H2-receptor blocker cimetidine, perfused at concentrations of 10(-7) to 10(-4) M failed to affect duodenal HCO3- output.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080297     DOI: 10.1007/bf01309331

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  6 in total

1.  Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate.

Authors:  R F Bauer; R G Bianchi; J Casler; B Goldstin
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  Demonstration of a pH gradient at the luminal surface of rat duodenum in vivo and its dependence on mucosal alkaline secretion.

Authors:  G Flemström; E Kivilaakso
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

3.  Surface epithelial HCO3(-) transport by mammalian duodenum in vivo.

Authors:  G Flemström; A Garner; O Nylander; B C Hurst; J R Heylings
Journal:  Am J Physiol       Date:  1982-11

4.  Gastric and duodenal HCO3- transport in vitro: effects of hormones and local transmitters.

Authors:  G Flemström; J R Heylings; A Garner
Journal:  Am J Physiol       Date:  1982-02

5.  The pH gradient across mucus adherent to rat fundic mucosa in vivo and the effect of potential damaging agents.

Authors:  I N Ross; H M Bahari; L A Turnberg
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

6.  Effect of graded doses of intraluminal H+, prostaglandin E2, and inhibition of endogenous prostaglandin synthesis on proximal duodenal bicarbonate secretion in unanesthetized rat.

Authors:  J I Isenberg; B Smedfors; C Johansson
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

  6 in total
  3 in total

Review 1.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

2.  Effect of misoprostol on concentrations of prostaglandins in synovial fluid.

Authors:  A Doube; J Davies; L Notarianni; K Holgate; G C Fenn
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Prostaglandins and the gastric epithelium: effects of misoprostol on gastric epithelial cell proliferation in the dog.

Authors:  R A Goodlad; A J Madgwick; M R Moffatt; S Levin; J L Allen; N A Wright
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.